Work at Olema.

Olema Oncology is a clinical-stage biopharmaceutical company focused on developing targeted therapies for breast cancer and other endocrine-driven cancers. Its lead programs include palazestrant (OP-1250) and a KAT6 inhibitor, positioning it as an oncology-focused...

Healthcare Biopharma Biotechnology Health Care Medical Oncology

Open roles 4

Founded 2006

Type Public · OLMA

Team size 51–200

Headquarters Dublin

Website olema.com

Legal name Olema Pharmaceuticals, Inc.

View on LinkedIn →

Open roles at Olema

4 open roles

Director, Commercial Data Science San Francisco · San Francisco Salary TBC 24 days ago

Director, Commercial Insights and Analytics San Francisco · San Francisco $230,000–$250,000 / year 71 days ago

Director, Commercial Insights and Analytics Boston · Boston $230,000–$250,000 / year 71 days ago

About Olema

Products & services

Palazestrant (OP-1250) An oral complete estrogen receptor antagonist for treating ER+/HER2- advanced or metastatic breast cancer.
OP-3136 KAT6 Inhibitor A selective KAT6 inhibitor under development for breast cancer and other solid tumors.

Leadership

Sean Bohen President & Chief Executive Officer
Peter Kushner Co-Founder and CSO
Cyrus L. Harmon Founder and CTO
Jason O’Byrne Chief Financial Officer

Work at Olema.

Open roles at Olema

Subscribe to Career Resources.

Your cookie choices